Aspira Women's Health Inc. (AWH)
NASDAQ: AWH · IEX Real-Time Price · USD
1.480
-0.010 (-0.67%)
At close: Jul 19, 2024, 4:00 PM
1.420
-0.060 (-4.05%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Aspira Women's Health Market Cap
Aspira Women's Health has a market cap or net worth of $18.43 million as of July 22, 2024. Its market cap has decreased by -25.70% in one year.
Market Cap
18.43M
Enterprise Value
17.44M
1-Year Change
-25.70%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since October 2, 2000, Aspira Women's Health's market cap has decreased from $896.90M to $18.43M, a decrease of -97.95%. That is a compound annual growth rate of -15.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 18.40M | -56.40% |
Dec 29, 2023 | 42.20M | 1.93% |
Dec 30, 2022 | 41.40M | -79.14% |
Dec 31, 2021 | 198.50M | -71.58% |
Dec 31, 2020 | 698.40M | 786.29% |
Dec 31, 2019 | 78.80M | 248.67% |
Dec 31, 2018 | 22.60M | -80.48% |
Dec 29, 2017 | 115.80M | 133.00% |
Dec 30, 2016 | 49.70M | -46.90% |
Dec 31, 2015 | 93.60M | 30.54% |
Dec 31, 2014 | 71.70M | 29.42% |
Dec 31, 2013 | 55.40M | 178.39% |
Dec 31, 2012 | 19.90M | 14.37% |
Dec 30, 2011 | 17.40M | -77.78% |
Dec 31, 2010 | 78.30M | -55.31% |
Dec 31, 2009 | 175.20M | 10,205.88% |
Dec 31, 2008 | 1.70M | -96.71% |
Dec 31, 2007 | 51.70M | 61.06% |
Dec 29, 2006 | 32.10M | -24.47% |
Dec 30, 2005 | 42.50M | -66.32% |
Dec 31, 2004 | 126.20M | -61.75% |
Dec 31, 2003 | 329.90M | 251.33% |
Dec 31, 2002 | 93.90M | -56.45% |
Dec 31, 2001 | 215.60M | -39.13% |
Dec 29, 2000 | 354.20M | -60.51% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vincerx Pharma | 19.29M |
MEI Pharma | 19.06M |
Kala Pharmaceuticals | 19.04M |
Cara Therapeutics | 18.84M |
iBio, Inc. | 18.54M |
GlycoMimetics | 18.33M |
Indaptus Therapeutics | 18.19M |
Synlogic | 18.15M |